anthracycline extravasation
Recently Published Documents


TOTAL DOCUMENTS

38
(FIVE YEARS 0)

H-INDEX

11
(FIVE YEARS 0)

2020 ◽  
pp. 107815522097584 ◽  
Author(s):  
Vera Kazakova ◽  
Yenny A Moreno Vanegas ◽  
Tyion A Torres ◽  
Olga Kozyreva

Introduction Intrathoracic extravasation of anthracyclines is a dangerous and very rare complication of chemotherapy administration. While management of extravasation into soft tissues has been established, the data on treatment of mediastinal and intrapleural anthracycline extravasation is limited. Case Report We present a case of a 52-year-old woman with intrapleural doxorubicin extravasation who presented to the hospital 24-hrs after chemotherapy infusion with chest pain and shortness of breath. Management & Outcome The patient underwent urgent surgical intervention and received IV dexrazoxane 36-hrs after the event. Her pain improved, but she continued to have chest soreness and pleural effusion at the site of extravasation even 3 months later. Discussion We conducted review of literature using Medline/PubMed and Google Scholar databases and identified 7 cases of intrapleural and mediastinal anthracycline extravasation. No data is currently available regarding the outcome of delayed management of intrapleural anthracycline extravasation with dexrazoxane. Prevention and confirmation of adequate port catheter placement is the most important step to avoid such cases. Catheter misplacement should be suspected in any patient presenting with post procedural chest pain and should trigger a thorough evaluation prior to any chemotherapy administration.


2017 ◽  
Vol 2 (2) ◽  
Author(s):  
Komla Sena Amouzou ◽  
Nabil Berny ◽  
Tiemoko Moulaye Haidara ◽  
Abdessamad Chlihi ◽  
Mohamed Ezzoubi

<p>Anthracycline extravasation remains a feared serious complication of chemotherapy. At late presentation, deep ulceration and extensive soft tissue damage are seen. Hand extravasation of anthracycline may lead to tendon and nerves destruction with functional and economical impairments. We report a case of Epirubicin extravasation seen at day 25 in a 46-year-old woman treated for breast cancer. A groin flap failed due to the persistence of anthracyclin in the wound. A split thickness skin graft was done after all the tendons were removed. The chemotherapy was interrupted for two months. Wide serial debridements are needed to achieve the removal of all molecules of anthracycline that are observed when granulating tissue is observed permanently in the wound.</p><p> </p>


2016 ◽  
Vol 2016 (10) ◽  
pp. omw079 ◽  
Author(s):  
Rachael Chang ◽  
Nick Murray

2013 ◽  
Vol 47 (5) ◽  
pp. 339-343 ◽  
Author(s):  
Sernaz Uzunoglu ◽  
Rusen Cosar ◽  
Irfan Cicin ◽  
Kamuran Ibis ◽  
Ebru Demiralay ◽  
...  

2013 ◽  
Vol 67 (3) ◽  
pp. 244-249 ◽  
Author(s):  
S. Muthuramalingam ◽  
J. Gale ◽  
J. Bradbury

2011 ◽  
pp. 114-116
Author(s):  
Seppo W. Langer

The treatment of accidental extravasation of anthracycline-based chemotherapy has markedly improved with the recent introduction of a systemic antidote, Savene. However, efficacy data on this treatment is mainly based on extravasation from peripheral catheters. This review presents data on 7 cases of Savene treatment of anthracycline extravasations from central venous catheters.


Sign in / Sign up

Export Citation Format

Share Document